Medicort

Dexamethasone, the active ingredient in Medicort, is a corticosteroid (glucocorticoid) presented as an oral formulation for systemic use. It is used to reduce inflammation and suppress immune responses in a range of conditions such as allergic reactions, asthma exacerbations, rheumatoid arthritis, dermatologic inflammatory disorders, and other autoimmune diseases.

GNH USA supplies Medicort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, with a focus on quality assurance and regulatory compliance for both acute and chronic therapy.

Dexamethasone is a glucocorticoid that modulates inflammatory and immune pathways.

Allergic reactions: reduces swelling, itching and airway constriction. Asthma exacerbations: decreases airway inflammation to improve breathing. Rheumatoid arthritis: alleviates joint pain and swelling by suppressing synovial inflammation. Dermatologic inflammatory conditions: diminishes skin redness, edema and lesions in disorders such as eczema or psoriasis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Increased appetite and weight gain. - Insomnia or mood changes. - Mild hyperglycemia. - Gastrointestinal discomfort or dyspepsia. - Facial flushing or skin thinning. - Muscle weakness.

Serious or Rare Side Effects: - Severe infections due to immunosuppression. - Adrenal insufficiency on abrupt discontinuation. - Osteoporosis and increased fracture risk. - Cataracts or glaucoma. - Severe hyperglycemia or diabetic ketoacidosis. - Psychosis or severe mood disorders.

Use of dexamethasone requires careful monitoring and patient education. - Blood glucose monitoring: assess for hyperglycemia, especially in diabetic patients. - Infection surveillance: watch for signs of bacterial, viral or fungal infections. - Bone health evaluation: consider calcium/vitamin D supplementation and bone density testing for long‑term use. - Dose minimisation: employ the lowest effective dose for the shortest duration possible. - Tapering plan: gradually reduce dose when discontinuing to avoid adrenal crisis. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Dexamethasone can alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase dexamethasone exposure. - Live vaccines: risk of uncontrolled infection due to immunosuppression. - Anticoagulants (warfarin): enhanced anticoagulant effect, requiring close INR monitoring.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce dexamethasone efficacy. - Antidiabetic agents: glucocorticoid‑induced hyperglycemia may necessitate dose adjustment of insulin or oral hypoglycemics.